Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Stomach Neoplasms 1Radiodermatitis 1Pancreatitis, Chronic 1Pancreatic Neoplasms 1Neuroma, Acoustic 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lung Neoplasms 1Lichen Planus, Oral 1Fibroma 1Exanthema 1Esophageal Stenosis Acquired 1Dupuytren Contracture 1Dermatitis, Contact 1Castration Resistant Prostate Cancer 1Breast Neoplasms 1

Interventions

Cochlear Implants 3Radiosurgery 2Lapatinib 2Everolimus 2Bevacizumab 2tozuleristide 1icotinib 1Triamcinolone Acetonide 1Temozolomide 1Sirolimus 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Mn-PyC3A 1Microsurgery 1Methylprednisolone 1Gentamicins 1Fluoresceins 1Fluorescein 1Exome 1Endostatins 1Axitinib 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neuroma, Acoustic × Triamcinolone Acetonide × Clear all
NCT04658836 2022-08-24

Triamcinolone Levels in Cochlear Perilymph, Lateral Canal and CSF

Medical University of Vienna

Phase 1 Completed
21 enrolled
CNS

Neuroma, Acoustic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡